PL2496228T3 - Sposoby leczenia zespołu nadpobudliwości psychoruchowej/deficytu uwagi - Google Patents
Sposoby leczenia zespołu nadpobudliwości psychoruchowej/deficytu uwagiInfo
- Publication number
- PL2496228T3 PL2496228T3 PL10828500T PL10828500T PL2496228T3 PL 2496228 T3 PL2496228 T3 PL 2496228T3 PL 10828500 T PL10828500 T PL 10828500T PL 10828500 T PL10828500 T PL 10828500T PL 2496228 T3 PL2496228 T3 PL 2496228T3
- Authority
- PL
- Poland
- Prior art keywords
- deficit
- methods
- hyperactivity disorder
- treating attention
- attention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25878009P | 2009-11-06 | 2009-11-06 | |
| EP10828500.8A EP2496228B1 (en) | 2009-11-06 | 2010-11-03 | Methods for treating attention-deficit/hyperactivity disorder |
| PCT/KR2010/007698 WO2011055965A2 (en) | 2009-11-06 | 2010-11-03 | Methods for treating attention-deficit/hyperactivity disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2496228T3 true PL2496228T3 (pl) | 2014-06-30 |
Family
ID=43970530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10828500T PL2496228T3 (pl) | 2009-11-06 | 2010-11-03 | Sposoby leczenia zespołu nadpobudliwości psychoruchowej/deficytu uwagi |
Country Status (14)
| Country | Link |
|---|---|
| US (6) | US8895609B2 (pl) |
| EP (1) | EP2496228B1 (pl) |
| JP (1) | JP5836280B2 (pl) |
| KR (1) | KR101783632B1 (pl) |
| CN (1) | CN102762201B (pl) |
| AU (1) | AU2010316106B2 (pl) |
| BR (1) | BR112012010670A2 (pl) |
| CA (1) | CA2779457C (pl) |
| ES (1) | ES2447295T3 (pl) |
| HK (1) | HK1178060A1 (pl) |
| MX (1) | MX2012005258A (pl) |
| PL (1) | PL2496228T3 (pl) |
| RU (1) | RU2556585C2 (pl) |
| WO (1) | WO2011055965A2 (pl) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1890684T3 (da) | 2005-06-08 | 2013-10-14 | Sk Biopharmaceuticals Co Ltd | Behandling af søvn/vågenhedsforstyrrelser |
| EP2445490B1 (en) | 2009-06-22 | 2023-02-08 | SK Biopharmaceuticals Co., Ltd. | Methods for treating or preventing fatigue |
| BR112012010648A2 (pt) | 2009-11-06 | 2020-12-01 | Sk Biopharmaceuticals Co., Ltd. | uso de compostos na preparação de composições farmacêuticas para tratar síndrome de fibromialgia e composição farmacêutica |
| JP5836280B2 (ja) | 2009-11-06 | 2015-12-24 | エスケー バイオファーマスティカルズ カンパニー リミテッド | 注意欠陥／多動性障害（ａｄｈｄ）の治療方法 |
| US9610274B2 (en) * | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
| HRP20221018T1 (hr) | 2013-03-13 | 2023-01-06 | Jazz Pharmaceuticals Ireland Limited | Liječenje katapleksije |
| JP2016530240A (ja) * | 2013-07-12 | 2016-09-29 | ジャズ ファーマスティカルズ インターナショナル スリー リミテッドＪａｚｚ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｉｉ Ｌｉｍｉｔｅｄ | 禁煙の促進 |
| TW201919605A (zh) | 2013-07-18 | 2019-06-01 | 南韓商愛思開生物製藥股份有限公司 | 肥胖之治療 |
| US10888542B2 (en) | 2014-02-28 | 2021-01-12 | Sk Biopharmaceuticals Co., Ltd. | Aminocarbonylcarbamate compounds |
| TWI698415B (zh) * | 2014-02-28 | 2020-07-11 | 南韓商愛思開生物製藥股份有限公司 | 胺基羰基胺基甲酸酯化合物 |
| JP6466792B2 (ja) * | 2015-07-03 | 2019-02-06 | エスケー バイオファーマスティカルズ カンパニー リミテッド | 注意欠陥／多動性障害（ａｄｈｄ）の治療方法 |
| US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
| KR102513800B1 (ko) | 2016-09-06 | 2023-03-24 | 에스케이바이오팜 주식회사 | (r)-2-아미노-3-페닐프로필 카바메이트의 용매화물 폼 |
| CA3039045A1 (en) | 2016-10-06 | 2018-04-12 | Jazz Pharmaceuticals International Iii Limited | Carbamoyl phenylalaninol compounds and uses thereof |
| WO2018222954A1 (en) | 2017-06-02 | 2018-12-06 | Jazz Pharmaceuticals International Iii Limited | Methods and compositions for treating excessive sleepiness |
| CN111094238B (zh) | 2017-07-31 | 2023-06-09 | 杰资制药爱尔兰有限公司 | 氨基甲酰基苯丙氨醇类似物及其用途 |
| CN109464151B (zh) * | 2018-12-29 | 2021-09-07 | 中国科学院深圳先进技术研究院 | 注意抑制能力获取方法、装置、设备及存储介质 |
| US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
| KR20240021189A (ko) * | 2021-06-11 | 2024-02-16 | 에스케이바이오팜 주식회사 | 자폐 스펙트럼 장애(asd)를 치료하는 방법 |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5836280B2 (ja) | 1976-11-08 | 1983-08-08 | 日本鋼管株式会社 | 焼結排ガス処理用熱交換器の水処理方法 |
| IL109872A (en) | 1993-06-10 | 2000-12-06 | Lilly Co Eli | Tetrahydrobenz ¬CD¾ indole-6-carboxamides for use in preventing emesis and pharmaceutical compositions comprising same |
| KR100197892B1 (ko) | 1994-09-09 | 1999-06-15 | 남창우 | 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법 |
| KR0173862B1 (ko) * | 1995-02-11 | 1999-04-01 | 조규향 | O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
| US5756817C1 (en) | 1995-02-11 | 2001-04-17 | Sk Corp | O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same |
| IT1275903B1 (it) | 1995-03-14 | 1997-10-24 | Boehringer Ingelheim Italia | Esteri e ammidi della 1,4-piperidina disostituita |
| KR0173863B1 (ko) | 1995-04-10 | 1999-04-01 | 조규향 | 페닐에 치환체가 있는 o-카바모일-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
| DE69618663T2 (de) | 1996-10-10 | 2002-08-14 | Sk Corp | O-carbamoyl-phenylalaninol-zusammensetzungen und ihre pharmazeutisch anwendbaren salzen |
| WO1998017636A1 (en) | 1996-10-22 | 1998-04-30 | Ortho Pharmaceutical Corporation | Phenylalaninol derivatives for the treatment of central nervous system disorders |
| TW548103B (en) | 1997-07-11 | 2003-08-21 | Janssen Pharmaceutica Nv | Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| WO1999021561A1 (en) * | 1997-10-29 | 1999-05-06 | Davis Bonnie M | Method for treatment of disorders of attention |
| IL138568A0 (en) | 1998-04-28 | 2001-10-31 | Dainippon Pharmaceutical Co | 1-[(1-substituted-4-piperidinyl) methyl] -4- piperidine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor |
| US20010029262A1 (en) | 1998-06-29 | 2001-10-11 | Sethi Kapil Dev | Method of treatment or prophylaxis |
| TW518218B (en) | 1999-05-27 | 2003-01-21 | Merck Patent Gmbh | Pharmaceutical compositions comprising 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine or its physiologically acceptable salts for use in the treatment of sub-type anxiety disorders |
| US20010034320A1 (en) | 2000-01-18 | 2001-10-25 | Hans-Michael Brecht | NK1-receptor antagonists for treating restless legs syndrome |
| AU2002231139B2 (en) | 2000-12-21 | 2007-03-22 | Bristol-Myers Squibb Company | Thiazolyl inhibitors of tec family tyrosine kinases |
| PT1404312E (pt) | 2001-02-27 | 2011-02-01 | Ortho Mcneil Pharm Inc | Compostos carbamato para utilização no tratamento de dor |
| ES2291454T3 (es) | 2001-02-27 | 2008-03-01 | Ortho-Mcneil Pharmaceutical, Inc. | Utilizacion de carbamatos para prevenir o tratar trastornos del movimiento. |
| CA2443108A1 (en) | 2001-04-03 | 2002-10-17 | Merck & Co. Inc. | N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists |
| CA2449249A1 (en) | 2001-06-12 | 2002-12-19 | Merck & Co., Inc. | Nr2b receptor antagonists for the treatment or prevention of migraines |
| US7189757B2 (en) * | 2001-10-16 | 2007-03-13 | Hypnion, Inc. | Treatment of sleep disorders using CNS target modulators |
| US20040115263A1 (en) | 2002-08-26 | 2004-06-17 | Robertson David W. | Use of bupropion for treating restless legs syndrome |
| AU2003259482A1 (en) | 2002-09-20 | 2004-04-08 | Pfizer Japan Inc. | N-substituted piperidinyl-imidazopyridine compounds as 5-ht4 receptor modulators |
| MXPA05011270A (es) | 2003-04-21 | 2006-01-24 | Pfizer | Compuestos de imidazopiridina que tienen actividad agonista del receptor 5-ht4 y actividad antagonista del receptor 5-ht3. |
| RS20060145A (en) | 2003-09-03 | 2008-06-05 | Pfizer Inc., | Benzimidazolone compounds having 5-ht4 receptor agonistic activity |
| US20050080268A1 (en) | 2003-10-08 | 2005-04-14 | Yong-Moon Choi | Process of preparing O-carbamoyl compounds in the presence of active amine group |
| US8304431B2 (en) | 2003-12-02 | 2012-11-06 | Pharmaneuroboost N.V. | Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| JP4571645B2 (ja) | 2003-12-02 | 2010-10-27 | ファルマニューロブースト エン．フェー． | Ｄ４および５−ｈｔ２ａアンタゴニスト、逆アゴニストまたは部分アゴニストの使用 |
| EP1548011A1 (en) | 2003-12-23 | 2005-06-29 | Neuro3D | Benzo[1,4]diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof |
| WO2005092882A1 (en) | 2004-03-01 | 2005-10-06 | Pfizer Japan, Inc. | 4-amino-5-halogeno-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, cns, neurological and cardiovascular disorders |
| JP4874526B2 (ja) | 2004-03-25 | 2012-02-15 | 株式会社東芝 | 磁気記録媒体及び磁気記録媒体の製造法、並びに磁気記録再生装置 |
| MX2007005172A (es) * | 2004-10-28 | 2007-06-22 | Sk Corp | Terapia adjunta para la depresion. |
| UA88518C2 (ru) | 2005-04-08 | 2009-10-26 | Пфайзер Продактс Инк. | Бицикло[3,1,0]гетероариламиды как ингибиторы транспорта глицина типа i |
| US7598279B2 (en) * | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
| DK1890684T3 (da) * | 2005-06-08 | 2013-10-14 | Sk Biopharmaceuticals Co Ltd | Behandling af søvn/vågenhedsforstyrrelser |
| JP5298334B2 (ja) * | 2005-06-22 | 2013-09-25 | エスケー ホルディングス カンパニー リミテッド | 性機能障害を治療する方法 |
| CN101534808A (zh) * | 2005-06-27 | 2009-09-16 | 拜维尔实验室国际有限公司 | 丁氨苯丙酮盐的改良释放配制品 |
| ES2385087T3 (es) | 2005-07-26 | 2012-07-18 | Sk Biopharmaceuticals Co., Ltd | Procedimientos para tratar trastornos relacionados con sustancias |
| EP1754476A1 (en) | 2005-08-18 | 2007-02-21 | Schwarz Pharma Ag | Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia |
| US20080031932A1 (en) * | 2006-08-04 | 2008-02-07 | Watson Laboratories, Inc. | Transdermal atomoxetine formulations and associated methods |
| CA2673487A1 (en) | 2006-10-13 | 2008-04-24 | Janssen Pharmaceutica Nv | Phenylalkylamino carbamate compositions |
| GB2443287B (en) | 2006-10-17 | 2009-05-27 | Lipothera Inc | Methods, compositions and formulations for the treatment of thyroid eye disease |
| HUP0700353A2 (en) * | 2007-05-18 | 2008-12-29 | Richter Gedeon Nyrt | Metabolites of (thio)carbamoyl-cyclohexane derivatives |
| US8642772B2 (en) | 2008-10-14 | 2014-02-04 | Sk Biopharmaceuticals Co., Ltd. | Piperidine compounds, pharmaceutical composition comprising the same and its use |
| EP2445490B1 (en) | 2009-06-22 | 2023-02-08 | SK Biopharmaceuticals Co., Ltd. | Methods for treating or preventing fatigue |
| US8232315B2 (en) | 2009-06-26 | 2012-07-31 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating drug addiction and improving addiction-related behavior |
| JP5836280B2 (ja) | 2009-11-06 | 2015-12-24 | エスケー バイオファーマスティカルズ カンパニー リミテッド | 注意欠陥／多動性障害（ａｄｈｄ）の治療方法 |
| BR112012010648A2 (pt) | 2009-11-06 | 2020-12-01 | Sk Biopharmaceuticals Co., Ltd. | uso de compostos na preparação de composições farmacêuticas para tratar síndrome de fibromialgia e composição farmacêutica |
| US8623913B2 (en) | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
-
2010
- 2010-11-03 JP JP2012537811A patent/JP5836280B2/ja active Active
- 2010-11-03 MX MX2012005258A patent/MX2012005258A/es active IP Right Grant
- 2010-11-03 CN CN2010800610445A patent/CN102762201B/zh active Active
- 2010-11-03 US US13/508,147 patent/US8895609B2/en active Active
- 2010-11-03 PL PL10828500T patent/PL2496228T3/pl unknown
- 2010-11-03 EP EP10828500.8A patent/EP2496228B1/en active Active
- 2010-11-03 ES ES10828500.8T patent/ES2447295T3/es active Active
- 2010-11-03 AU AU2010316106A patent/AU2010316106B2/en active Active
- 2010-11-03 WO PCT/KR2010/007698 patent/WO2011055965A2/en active Application Filing
- 2010-11-03 RU RU2012123155/15A patent/RU2556585C2/ru active
- 2010-11-03 CA CA2779457A patent/CA2779457C/en not_active Expired - Fee Related
- 2010-11-03 BR BR112012010670A patent/BR112012010670A2/pt not_active Application Discontinuation
- 2010-11-03 KR KR1020127014768A patent/KR101783632B1/ko active IP Right Grant
-
2013
- 2013-04-26 HK HK13105110.9A patent/HK1178060A1/xx unknown
-
2014
- 2014-09-24 US US14/495,532 patent/US9663455B2/en active Active
-
2017
- 2017-05-25 US US15/605,278 patent/US10202335B2/en active Active
-
2018
- 2018-12-19 US US16/225,893 patent/US20190194125A1/en not_active Abandoned
-
2020
- 2020-09-23 US US17/029,151 patent/US11524935B2/en active Active
-
2022
- 2022-12-07 US US18/062,911 patent/US20230278950A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2496228A4 (en) | 2013-04-10 |
| US20120245226A1 (en) | 2012-09-27 |
| JP2013527127A (ja) | 2013-06-27 |
| WO2011055965A3 (en) | 2011-10-20 |
| CA2779457A1 (en) | 2011-05-12 |
| CN102762201B (zh) | 2013-12-18 |
| AU2010316106B2 (en) | 2015-10-22 |
| MX2012005258A (es) | 2012-06-19 |
| CA2779457C (en) | 2017-10-17 |
| EP2496228B1 (en) | 2014-01-15 |
| KR101783632B1 (ko) | 2017-10-10 |
| US20150025137A1 (en) | 2015-01-22 |
| RU2556585C2 (ru) | 2015-07-10 |
| RU2012123155A (ru) | 2013-12-20 |
| AU2010316106A1 (en) | 2012-05-24 |
| ES2447295T3 (es) | 2014-03-11 |
| CN102762201A (zh) | 2012-10-31 |
| US20170355668A1 (en) | 2017-12-14 |
| US20190194125A1 (en) | 2019-06-27 |
| US20210070694A1 (en) | 2021-03-11 |
| JP5836280B2 (ja) | 2015-12-24 |
| US8895609B2 (en) | 2014-11-25 |
| US9663455B2 (en) | 2017-05-30 |
| US11524935B2 (en) | 2022-12-13 |
| BR112012010670A2 (pt) | 2016-04-12 |
| US10202335B2 (en) | 2019-02-12 |
| HK1178060A1 (en) | 2013-09-06 |
| KR20120080656A (ko) | 2012-07-17 |
| US20230278950A1 (en) | 2023-09-07 |
| EP2496228A2 (en) | 2012-09-12 |
| WO2011055965A2 (en) | 2011-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1178060A1 (en) | Methods for treating attention-deficit/hyperactivity disorder | |
| IL257418A (en) | Methods for treating addiction | |
| HK1204244A1 (en) | Methods for treating spine pathologies | |
| PL2338519T3 (pl) | Środek do leczenia zwłóknienia szpiku | |
| PT2248083T (pt) | Método de autenticação | |
| EP2558109A4 (en) | METHOD FOR TREATING HARD TUMORS | |
| EP2496227A4 (en) | METHODS FOR TREATING A FIBROMYALGIA SYNDROME | |
| IL209895A0 (en) | Compounds for treating beta-amyloidoses | |
| SI3412687T1 (sl) | Postopek zdravljenja DLBCL | |
| SG11201406192VA (en) | Method for assessing the treatment of attention-deficit/hyperactivity disorder | |
| HK1203516A1 (en) | Methods for treating psoriasis | |
| PT2096102E (pt) | Processo para a produção de metileno-difenil-diisocianatos | |
| PL2526141T3 (pl) | Sposób obróbki powierzchniowej | |
| PL2301893T3 (pl) | Sposób oczyszczania ścieku | |
| IL218633A0 (en) | Methods for treating psoriasis | |
| EP2453896A4 (en) | PROCESS FOR TREATING SCHIZOPHRENIA | |
| EP2331097A4 (en) | METHOD FOR TREATING CNS DISEASES | |
| EP2654749A4 (en) | PROCESS FOR TREATING COPD | |
| EP2630489A4 (en) | METHODS OF SELECTING A MEDICAMENT FOR THE TREATMENT OF PATIENTS WITH A ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY | |
| IL232897A0 (en) | Pacetopran for the treatment of attention, concentration and hyperactivity disorder | |
| GB2483039B (en) | Method for treating hydrocarbons | |
| GB0912227D0 (en) | Compounds for treating proliferative disorders | |
| GB0912376D0 (en) | Compounds for treating proliferative disorders | |
| TWM369999U (en) | Urging apparatus for anti-floodgate | |
| ZA201000867B (en) | Methods for treating dependence |